Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

time to treatment failure

  • You have access
    Extracellular Water-to-total Body Water Ratio as an Objective Biomarker for Frailty in Lung Cancer Patients
    TOMONORI HIRASHIMA, YOSHIMI NODA, HIDEKAZU SUZUKI, SHINGO NASU, AYAKO TANAKA, NAOKO MORISHITA, NORIKO RYOTA, KAORI IWATA, YUKARI OKADA and NORIO OKAMOTO
    Anticancer Research March 2021, 41 (3) 1655-1662; DOI: https://doi.org/10.21873/anticanres.14928
  • You have access
    Significance of Pre-treatment Interferon-gamma Release in Patients With Non-small-cell Lung Cancer Receiving Immune Checkpoint Inhibitors
    TOMONORI HIRASHIMA, TOMOHIRO KANAI, HIDEKAZU SUZUKI, HIROKO YOSHIDA, AKANE MATSUSITA, HIROMI KAWASUMI, SHINGO NASU, AYAKO TANAKA, NAOKO MORISHITA, KUNIMITSU KAWAHARA, YOSHITAKA TAMURA and NORIO OKAMOTO
    Anticancer Research December 2020, 40 (12) 6971-6978; DOI: https://doi.org/10.21873/anticanres.14721
  • You have access
    Cancer Cachexia Reduces the Efficacy of Nivolumab Treatment in Patients With Advanced Gastric Cancer
    HIRONORI FUJII, AKITAKA MAKIYAMA, HIROTOSHI IIHARA, NAOKI OKUMURA, SENRI YAMAMOTO, TAKEHARU IMAI, SHINICHIRO ARAKAWA, RYO KOBAYASHI, YOSHIHIRO TANAKA, KAZUHIRO YOSHIDA and AKIO SUZUKI
    Anticancer Research December 2020, 40 (12) 7067-7075; DOI: https://doi.org/10.21873/anticanres.14734
  • You have access
    Comparison of Tolerability Between 2-Weekly and 3-Weekly Docetaxel Regimen in Castration-resistant Prostate Cancer
    YUSUKE SHIMURA, YUKIO SUGA, SHINGO ITAI, HIROAKI IWAMOTO, YUTA TAKEZAWA, HIROSHI YAEGASHI, KOUJI IZUMI, TSUTOMU SHIMADA, YOSHIMICHI SAI, RYO MATSUSHITA and ATSUSHI MIZOKAMI
    Anticancer Research August 2020, 40 (8) 4291-4297; DOI: https://doi.org/10.21873/anticanres.14431
  • You have access
    Prophylactic Effect of Oral Minocycline in Combination with Topical Steroid and Skin Care Against Panitumumab-induced Acneiform Rash in Metastatic Colorectal Cancer Patients
    MAYA YAMADA, HIROTOSHI IIHARA, HIRONORI FUJII, MASASHI ISHIHARA, NOBUHISA MATSUHASHI, TAKAO TAKAHASHI, KAZUHIRO YOSHIDA and YOSHINORI ITOH
    Anticancer Research November 2015, 35 (11) 6175-6181;
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire